ICU MEDICAL INC (ICUI) Forecast, Price Target & Analyst Ratings

NASDAQ:ICUIUS44930G1076

Current stock price

130.55 USD
+3.59 (+2.83%)
At close:
130.55 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ICU MEDICAL INC (ICUI).

Forecast Snapshot

Consensus Price Target

Price Target
$187.27
+ 43.45% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
$1.80
Revenue Estimate
532.75M

ChartMill Buy Consensus

Rating
83.33%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$187.27
Upside
+ 43.45%
From current price of $130.55 to mean target of $187.27, Based on 12 analyst forecasts
Low
$179.78
Median
$183.60
High
$210.00

Price Target Revisions

1 Month
1.21%
3 Months
1.21%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for ICUI. The average price target is 187.27 USD. This implies a price increase of 43.45% is expected in the next year compared to the current price of 130.55.
The average price target has been revised upward by 1.21% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

ICUI Current Analyst RatingICUI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

ICUI Historical Analyst RatingsICUI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
83.33%
ICUI was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ICUI.
In the previous month the buy percentage consensus was at a similar level.
ICUI was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-20KeybancMaintains Overweight -> Overweight
2026-02-20Piper SandlerMaintains Overweight -> Overweight
2025-11-07KeybancMaintains Overweight -> Overweight
2025-11-07Piper SandlerMaintains Overweight -> Overweight
2025-10-21KeybancMaintains Overweight -> Overweight
2025-09-10Piper SandlerMaintains Overweight -> Overweight
2025-08-15Piper SandlerInitiate Overweight
2025-08-08Raymond JamesMaintains Strong Buy -> Strong Buy
2025-05-09Raymond JamesMaintains Strong Buy -> Strong Buy
2025-04-21KeybancMaintains Overweight -> Overweight
2025-04-08NeedhamReiterate Hold -> Hold
2024-12-11JefferiesUpgrade Hold -> Buy
2024-11-13NeedhamReiterate Hold
2024-11-13KeybancMaintains Overweight -> Overweight
2024-10-15KeybancMaintains Overweight -> Overweight
2024-10-14JefferiesInitiate Hold
2024-10-10NeedhamReiterate Hold
2024-09-12Raymond JamesMaintains Outperform -> Outperform
2024-08-08NeedhamReiterate Hold
2024-08-08KeybancMaintains Overweight -> Overweight
2024-08-08Raymond JamesMaintains Outperform -> Outperform
2024-06-21NeedhamInitiate Hold
2024-06-17Raymond JamesUpgrade Market Perform -> Outperform
2024-02-28KeybancMaintains Overweight -> Overweight
2024-02-06KeybancInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
$1.80
Revenue Estimate
532.75M
Revenue Q2Q
-11.13%
EPS Q2Q
4.37%
Number of Analysts
8

Next Earnings Revisions

Revenue (1 Month)
-0.21%
Revenue (3 Months)
-0.21%
EPS (1 Month)
-1.51%
EPS (3 Months)
-1.51%

Next Earnings Summary

ICUI is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is 1.8 USD and the consensus revenue estimate is 532.75M USD.
The next earnings revenue estimate has been revised downward by 0.21% in the past 3 months.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
ICUI revenue by date.ICUI revenue by date.
2.259B
-0.92%
2.382B
5.44%
2.231B
-6.33%
2.22B
-0.50%
2.319B
4.46%
2.475B
6.73%
2.637B
6.55%
2.803B
6.30%
EBITDA
YoY % growth
ICUI ebitda by date.ICUI ebitda by date.
292.857M
11.06%
322.316M
10.06%
310.075M
-3.80%
426.3M
37.48%
463.72M
8.78%
510.31M
10.05%
555.18M
8.79%
589.76M
6.23%
EBIT
YoY % growth
ICUI ebit by date.ICUI ebit by date.
64.083M
124.85%
102.804M
60.42%
109.334M
6.35%
356.1M
225.70%
392.41M
10.20%
441.46M
12.50%
N/AN/A
Operating Margin
ICUI operating margin by date.ICUI operating margin by date.
2.84%4.32%4.90%16.04%16.92%17.84%N/AN/A
EPS
YoY % growth
ICUI eps by date.ICUI eps by date.
6.76
3.36%
6.22
-7.99%
7.76
24.76%
8.27
6.62%
9.39
13.45%
10.29
9.59%
11.23
9.17%
12.07
7.45%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
1.80
4.37%
1.96
-6.63%
2.06
1.61%
2.26
18.18%
2.13
18.69%
2.28
16.13%
2.35
13.99%
2.54
12.70%
Revenue
Q2Q % growth
532.75M
-11.13%
542.9M
-0.12%
559.47M
4.91%
560.49M
4.58%
557.33M
4.61%
564.06M
3.90%
581.2M
3.88%
581.2M
3.69%
EBITDA
Q2Q % growth
98.056M
24.07%
102.92M
-18.26%
107.66M
-39.10%
110.62M
-51.23%
111.69M
13.90%
113.93M
10.70%
118.93M
10.47%
121.38M
9.73%
EBIT
Q2Q % growth
79.305M
168.06%
84.66M
215.84%
87.465M
225.67%
91.035M
248.97%
85.272M
7.52%
88.026M
3.98%
93.534M
6.94%
96.492M
5.99%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ICUI Yearly Revenue VS EstimatesICUI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
ICUI Yearly EPS VS EstimatesICUI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
9.85%
EPS Next 5 Year
9.23%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
3.23%
Revenue Next 5 Year
4.49%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
15.51%
EBIT Next 5 Year
12.24%

ICU MEDICAL INC / ICUI Forecast FAQ

What is the price target for ICUI stock?

12 analysts have analysed ICUI and the average price target is 187.27 USD. This implies a price increase of 43.45% is expected in the next year compared to the current price of 130.55.

Can you provide the upcoming earnings date for ICU MEDICAL INC?

ICU MEDICAL INC (ICUI) will report earnings on 2026-05-06.

What are the consensus estimates for ICUI stock next earnings?

The consensus EPS estimate for the next earnings of ICU MEDICAL INC (ICUI) is 1.8 USD and the consensus revenue estimate is 532.75M USD.

Can you provide the consensus rating for ICU MEDICAL INC stock?

The consensus rating for ICU MEDICAL INC (ICUI) is 83.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.